Helicobacter pylori (H. pylori) is one of the most common bacterial infections in the world, estimated to affect over 50% of the global population. Despite its prevalence, many people carry H. pylori without knowing it — and the infection can silently contribute to serious digestive and systemic health issues.
What Is H. pylori?
H. pylori is a spiral-shaped bacterium that colonizes the stomach lining. It has evolved sophisticated mechanisms to survive in the highly acidic stomach environment, including the production of urease enzyme which neutralizes stomach acid in its immediate vicinity. This allows it to burrow into the mucous lining and establish a chronic infection.
Symptoms of H. pylori Infection
Many H. pylori infections are asymptomatic. When symptoms do occur, they may include chronic upper abdominal pain or burning, bloating and excessive gas, nausea, loss of appetite, unexplained weight loss, acid reflux or heartburn, iron deficiency anemia, and fatigue. In more severe cases, H. pylori can lead to gastric and duodenal ulcers and is classified as a Group 1 carcinogen by the WHO due to its association with gastric cancer.
Why Virulence Factors Matter
Not all H. pylori strains are equally harmful. The GI-MAP™ test uniquely detects 8 virulence factors that indicate the aggressiveness and pathogenic potential of an H. pylori infection:
cagA (cytotoxin-associated gene A): Associated with increased risk of gastric cancer, peptic ulcers, and more severe inflammation. vacA (vacuolating cytotoxin A): Causes damage to epithelial cells and modulates immune response. babA (blood group antigen-binding adhesin): Facilitates adherence to gastric epithelium. dupA (duodenal ulcer promoting gene): Associated with duodenal ulcer development. oipA (outer inflammatory protein): Enhances mucosal inflammation. iceA (induced by contact with epithelium): Activated during contact with gastric cells. virB and virD: Part of the type IV secretion system used to inject toxins into host cells.
GI-MAP™ Detection Advantage
The GI-MAP™'s qPCR technology can detect H. pylori at the DNA level, even when the organism is present in very low quantities or is not actively culturable. Combined with virulence factor testing, this gives practitioners a complete picture of the infection that guides treatment decisions. A cagA-positive, vacA-positive strain may warrant more aggressive treatment than a strain without these factors.